LGG/BB12-pastille Study

This study has been completed.
Sponsor:
Collaborators:
University of Michigan
The Forsyth Institute
Information provided by (Responsible Party):
Eva Soderling, University of Turku
ClinicalTrials.gov Identifier:
NCT01577485
First received: April 12, 2012
Last updated: January 3, 2013
Last verified: January 2013
  Purpose

We want to study the effect of short-term consumption of probiotics (a mixture of L. rhamnosus GG and B. lactis BB-12)on the composition of the oral flora.


Condition Intervention Phase
Probiotics
Dietary Supplement: Probiotics in an pastille
Dietary Supplement: Control pastille
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
Primary Purpose: Screening
Official Title: LGG/BB12-pastille Study

Further study details as provided by University of Turku:

Primary Outcome Measures:
  • Counts of mutans streptococci [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Amount of plaque [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]

Enrollment: 60
Study Start Date: August 2012
Study Completion Date: November 2012
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Probiotic pastille
Test group
Dietary Supplement: Probiotics in an pastille
Test group
Active Comparator: Control pastille
Control group
Dietary Supplement: Control pastille
Control group

  Eligibility

Ages Eligible for Study:   20 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Subjects healthy, 20-30 yrs of age

Exclusion Criteria:

  • Subjects not healthy, too old/young
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01577485

Locations
Finland
Institute of Dentistry
Turku, Finland, 20520
Sponsors and Collaborators
University of Turku
University of Michigan
The Forsyth Institute
Investigators
Principal Investigator: Eva M Söderling Associate Professor
  More Information

No publications provided

Responsible Party: Eva Soderling, Associate Professor, University of Turku
ClinicalTrials.gov Identifier: NCT01577485     History of Changes
Other Study ID Numbers: ETMK:22/180/2012
Study First Received: April 12, 2012
Last Updated: January 3, 2013
Health Authority: Finland: Ethics Committee

ClinicalTrials.gov processed this record on August 27, 2014